World
EpiVax Adds AI-Enabled Enhancements to ISPRI Immunogenicity Risk Platform
EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the ...
September 04, 2026 | News
Genprex Selects Andelyn Biosciences to Scale Up AAV Gene Therapy for Diabetes
Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up m...
September 03, 2026 | News
IDT and Ansa Expand Global Access to Complex DNA Synthesis Through Integrated Ordering
Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400...
September 03, 2026 | News
US FDA Grants Fast Track Designation to T-MAXIMUM’s Allogeneic CAR-T Therapy for Recurrent Glioblastoma
T-MAXIMUM PHARMACEUTICAL Inc. ("T-MAXIMUM") announced that its investigational allogeneic CAR-T cell therapy MT027 has been granted Fast Track Designation ...
September 02, 2026 | News
Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain
Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreemen...
September 02, 2026 | News
Ascletis Doses First Patient in Global Phase III Programme for Oral GLP-1 Obesity Drug ASC30
- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and...
September 01, 2026 | News
WuXi AppTec Raises 2026 Interim Dividend to RMB 1.51 Billion Amid Global CRDMO Expansion
WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organizati...
September 01, 2026 | News
HiRO and Differentia Join Forces to Advance AI-Powered Clinical Trial Simulation and Digital Twins
Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities The partnership unites global clinic...
August 31, 2026 | News
Thermo Fisher Launches EMPAD G2 Detector to Advance High-Speed 4D STEM Imaging
Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Thermo Scientific™ EMPAD™ G2 detector, a new detector design...
August 28, 2026 | News
ReviR Therapeutics’ RTX-117 Secures FDA Rare Pediatric Disease Designation for Charcot-Marie-Tooth Disease
Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority Review Voucher, subject to approv...
August 28, 2026 | News
Biosidus Expands Biologics Manufacturing Capacity with New Bioreactor Plant in Argentina
Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announ...
August 28, 2026 | News
US FDA Approves BeOne’s TEVIMBRA-ZIIHERA Combination for First-Line HER2+ Gastroesophageal Cancer
TEVIMBRA plus ZIIHERA and chemotherapy is the first and only immunotherapy-based regimen to deliver more than two years of median OS in first-line HER2+ ...
August 27, 2026 | News
Thermo Fisher Launches First Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis
New Orbitrap Isora workflow integrates mass spectrometry, Vanquish Duo UHPLC System and Isotope Discoverer Software to bring molecular-level isotope ratio ...
August 26, 2026 | News
Biocon Partners with Innomar Strategies to Strengthen Canada Supply Chain
Biocon has partnered with Innomar Strategies, a healthcare services and logistics company, to strengthen its pharmaceutical supply chain and distribution n...
August 25, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
